These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30356415)

  • 1. Effects of Selenium Supplementation on Graves' Disease: A Systematic Review and Meta-Analysis.
    Zheng H; Wei J; Wang L; Wang Q; Zhao J; Chen S; Wei F
    Evid Based Complement Alternat Med; 2018; 2018():3763565. PubMed ID: 30356415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study.
    Wang L; Wang B; Chen SR; Hou X; Wang XF; Zhao SH; Song JQ; Wang YG
    Horm Metab Res; 2016 Sep; 48(9):559-64. PubMed ID: 27392116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between selenium levels and autoimmune thyroid disease: a systematic review and meta-analysis.
    Zuo Y; Li Y; Gu X; Lei Z
    Ann Palliat Med; 2021 Apr; 10(4):4398-4408. PubMed ID: 33894732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease.
    Xu B; Wu D; Ying H; Zhang Y
    Turk J Med Sci; 2019 Jun; 49(3):715-722. PubMed ID: 31023005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis.
    Wichman J; Winther KH; Bonnema SJ; Hegedüs L
    Thyroid; 2016 Dec; 26(12):1681-1692. PubMed ID: 27702392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
    Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
    Trials; 2013 Apr; 14():119. PubMed ID: 23782950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium supplementation for Hashimoto's thyroiditis.
    van Zuuren EJ; Albusta AY; Fedorowicz Z; Carter B; Pijl H
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010223. PubMed ID: 23744563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
    Katahira M; Tsunekawa T; Mizoguchi A; Yamaguchi M; Tsuru K; Takashima H; Terada R
    Hormones (Athens); 2023 Jun; 22(2):253-261. PubMed ID: 36811756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy.
    Bednarczuk T; Schomburg L
    Hormones (Athens); 2020 Mar; 19(1):31-39. PubMed ID: 31721133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine as an adjuvant therapy in severe Graves' disease: a randomized controlled open-label clinical trial.
    Allam MM; El-Zawawy HT; Kader Okda AA; Ali Alshaikh A; Ghazy RM
    Front Endocrinol (Lausanne); 2023; 14():1168936. PubMed ID: 37409226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis.
    Winther KH; Wichman JE; Bonnema SJ; Hegedüs L
    Endocrine; 2017 Feb; 55(2):376-385. PubMed ID: 27683225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
    Magri F; Zerbini F; Gaiti M; Capelli V; Ragni A; Rotondi M; Chiovato L
    Endocr Pract; 2016 Nov; 22(11):1336-1342. PubMed ID: 27540885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
    Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
    BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
    Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
    Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.
    Shi H; Sheng R; Hu Y; Liu X; Jiang L; Wang Z; Cui D
    Clin Ther; 2020 Apr; 42(4):662-675.e4. PubMed ID: 32139177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease.
    Hu Y; Man Y; Sun X; Xue Y
    Ital J Pediatr; 2021 Mar; 47(1):46. PubMed ID: 33653401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.